• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌预防旅行者腹泻的疗效:一项随机对照试验的适应性荟萃分析。

Prophylactic efficacy of probiotics on travelers' diarrhea: an adaptive meta-analysis of randomized controlled trials.

机构信息

Department of Preventive Medicine, Jeju National University School of Medicine, Jeju, Korea.

出版信息

Epidemiol Health. 2018;40:e2018043. doi: 10.4178/epih.e2018043. Epub 2018 Aug 29.

DOI:10.4178/epih.e2018043
PMID:30189723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6232657/
Abstract

OBJECTIVES

The 2017 guideline for the prevention of travelers' diarrhea (TD) by the International Society of Travel Medicine suggested that 'there is insufficient evidence to recommend the use of commercially available prebiotics or probiotics to prevent or treat TD.' However, a meta-analysis published in 2007 reported significant efficacy of probiotics in the prevention of TD (summary relative risk [sRR], 0.85, 95% confidence interval [CI], 0.79 to 0.91). This study aimed to synthesize the efficacy of probiotics on TD by updating the meta-analysis of double-blind, placebo-controlled, randomized human trials.

METHODS

The search process was conducted by the adaptive meta-analysis method using the 'cited by' and 'similar articles' options provided by PubMed. The inclusion criteria were double-blind, placebo-controlled, randomized human trials with hypotheses of probiotics as intervention and TD as an outcome. The adaptive meta-analysis was conducted using Stata software using the csi, metan, metafunnel, and metabias options.

RESULTS

Eleven articles were selected for the meta-analysis. The sRR was 0.85 (95% CI, 0.79 to 0.91) and showed statistical significance. There was no heterogeneity (I-squared=28.4%) and no publication bias.

CONCLUSIONS

Probiotics showed statistically significant efficacy in the prevention of TD.

摘要

目的

国际旅游医学学会 2017 年旅行者腹泻预防指南建议,“没有足够的证据推荐使用市售的益生元和益生菌来预防或治疗旅行者腹泻。”然而,2007 年发表的一项荟萃分析报告称益生菌在预防旅行者腹泻方面具有显著疗效(汇总相对风险 [sRR],0.85,95%置信区间 [CI],0.79 至 0.91)。本研究旨在通过更新双盲、安慰剂对照、随机人体试验的荟萃分析来综合益生菌对旅行者腹泻的疗效。

方法

通过使用 PubMed 提供的“被引文献”和“相似文章”选项,采用适应性荟萃分析方法进行检索过程。纳入标准为双盲、安慰剂对照、随机人体试验,假设益生菌作为干预措施,旅行者腹泻作为结局。采用 Stata 软件中的 csi、metan、metafunnel 和 metabias 选项进行适应性荟萃分析。

结果

共有 11 篇文章被纳入荟萃分析。sRR 为 0.85(95%CI,0.79 至 0.91),具有统计学意义。无异质性(I-squared=28.4%)和发表偏倚。

结论

益生菌在预防旅行者腹泻方面具有统计学上的显著疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b3/6232657/6d20910edf4a/epih-40-e2018043f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b3/6232657/606acf95333e/epih-40-e2018043f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b3/6232657/cb60919cbd47/epih-40-e2018043f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b3/6232657/6d20910edf4a/epih-40-e2018043f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b3/6232657/606acf95333e/epih-40-e2018043f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b3/6232657/cb60919cbd47/epih-40-e2018043f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89b3/6232657/6d20910edf4a/epih-40-e2018043f3.jpg

相似文献

1
Prophylactic efficacy of probiotics on travelers' diarrhea: an adaptive meta-analysis of randomized controlled trials.益生菌预防旅行者腹泻的疗效:一项随机对照试验的适应性荟萃分析。
Epidemiol Health. 2018;40:e2018043. doi: 10.4178/epih.e2018043. Epub 2018 Aug 29.
2
Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials.利福昔明预防旅行者腹泻的疗效:随机、双盲、安慰剂对照试验的荟萃分析。
J Travel Med. 2012 Dec;19(6):352-6. doi: 10.1111/j.1708-8305.2012.00650.x. Epub 2012 Sep 14.
3
Meta-analysis of probiotics for the prevention of traveler's diarrhea.益生菌预防旅行者腹泻的荟萃分析。
Travel Med Infect Dis. 2007 Mar;5(2):97-105. doi: 10.1016/j.tmaid.2005.10.003. Epub 2005 Dec 5.
4
Are probiotics and prebiotics effective in the prevention of travellers' diarrhea: A systematic review and meta-analysis.益生菌和益生元在预防旅行者腹泻中的有效性:系统评价和荟萃分析。
Travel Med Infect Dis. 2019 Jan-Feb;27:11-19. doi: 10.1016/j.tmaid.2018.09.007. Epub 2018 Sep 29.
5
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.益生菌用于预防成人和儿童艰难梭菌相关性腹泻
Cochrane Database Syst Rev. 2013 May 31(5):CD006095. doi: 10.1002/14651858.CD006095.pub3.
6
A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea.一项口服共生菌(AKSB)预防旅行者腹泻的随机、双盲、安慰剂对照试验。
J Travel Med. 2013 Mar-Apr;20(2):88-94. doi: 10.1111/jtm.12008. Epub 2013 Jan 25.
7
Investigating the influence of probiotics in preventing Traveler's diarrhea: Meta-analysis based systematic review.探讨益生菌预防旅行者腹泻的影响:基于荟萃分析的系统评价。
Travel Med Infect Dis. 2024 May-Jun;59:102703. doi: 10.1016/j.tmaid.2024.102703. Epub 2024 Mar 7.
8
Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials.益生菌用于婴幼儿急性感染性腹泻的治疗与预防:已发表的随机、双盲、安慰剂对照试验的系统评价
J Pediatr Gastroenterol Nutr. 2001 Oct;33 Suppl 2:S17-25. doi: 10.1097/00005176-200110002-00004.
9
Probiotics and rifaximin for the prevention of travelers' diarrhea: A systematic review and network meta-analysis.益生菌和利福昔明预防旅行者腹泻:系统评价和网络荟萃分析。
Medicine (Baltimore). 2022 Oct 7;101(40):e30921. doi: 10.1097/MD.0000000000030921.
10
Probiotics for prevention of radiation-induced diarrhea: A meta-analysis of randomized controlled trials.益生菌预防放射性腹泻:随机对照试验的荟萃分析
PLoS One. 2017 Jun 2;12(6):e0178870. doi: 10.1371/journal.pone.0178870. eCollection 2017.

引用本文的文献

1
Bismuth subsalicylate, probiotics, rifaximin and vaccines for the prevention of travelers' diarrhea: a systematic review and network meta-analysis.次水杨酸铋、益生菌、利福昔明及预防旅行者腹泻的疫苗:一项系统评价和网状Meta分析
Front Pharmacol. 2024 Apr 18;15:1361501. doi: 10.3389/fphar.2024.1361501. eCollection 2024.
2
The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties.益生菌对人类健康的潜在影响:关于其促进健康特性的最新进展
Microorganisms. 2024 Jan 23;12(2):234. doi: 10.3390/microorganisms12020234.
3
Probiotics, their prophylactic and therapeutic applications in human health development: A review of the literature.

本文引用的文献

1
Can a galacto-oligosaccharide reduce the risk of traveller's diarrhoea? A placebo-controlled, randomized, double-blind study.半乳糖寡糖能否降低旅行者腹泻的风险?一项安慰剂对照、随机、双盲研究。
J Travel Med. 2017 Sep 1;24(5). doi: 10.1093/jtm/tax057.
2
Probiotics for Gastrointestinal Conditions: A Summary of the Evidence.用于胃肠道疾病的益生菌:证据总结
Am Fam Physician. 2017 Aug 1;96(3):170-178.
3
Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report.旅行者腹泻防治指南:一份分级专家小组报告。
益生菌及其在人类健康发展中的预防和治疗应用:文献综述
Heliyon. 2022 Jun 22;8(6):e09725. doi: 10.1016/j.heliyon.2022.e09725. eCollection 2022 Jun.
4
Phenotypic Assessment of Probiotic and Bacteriocinogenic Efficacy of Indigenous LAB Strains from Human Breast Milk.人母乳中本土乳酸菌菌株的益生菌和产细菌素功效的表型评估
Curr Issues Mol Biol. 2022 Feb 1;44(2):731-749. doi: 10.3390/cimb44020051.
5
Multi-targeted properties of the probiotic CNCM I-3856 against enterotoxigenic (ETEC) H10407 pathogenesis across human gut models.益生菌 CNCM I-3856 针对肠致病性(ETEC)H10407 发病机制的多靶点特性在人体肠道模型中的研究。
Gut Microbes. 2021 Jan-Dec;13(1):1953246. doi: 10.1080/19490976.2021.1953246.
6
Gut Microbiota-targeted Interventions for Reducing the Incidence, Duration, and Severity of Respiratory Tract Infections in Healthy Non-elderly Adults.靶向肠道微生物群的干预措施可降低健康非老年成年人呼吸道感染的发生率、持续时间和严重程度。
Mil Med. 2021 Feb 26;186(3-4):e310-e318. doi: 10.1093/milmed/usaa261.
7
Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective.益生菌的治疗、预防及功能应用:当前观点
Front Microbiol. 2020 Sep 11;11:562048. doi: 10.3389/fmicb.2020.562048. eCollection 2020.
8
Probiotics and prebiotics in clinical tests: an update.临床试验中的益生菌和益生元:最新进展
F1000Res. 2019 Jul 22;8. doi: 10.12688/f1000research.19043.1. eCollection 2019.
9
Travelers' Diarrhea: A Clinical Review.旅行者腹泻:临床综述
Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):38-48. doi: 10.2174/1872213X13666190514105054.
10
Probiotics: Reiterating What They Are and What They Are Not.益生菌:重申其是什么以及不是什么。
Front Microbiol. 2019 Mar 12;10:424. doi: 10.3389/fmicb.2019.00424. eCollection 2019.
J Travel Med. 2017 Apr 1;24(suppl_1):S57-S74. doi: 10.1093/jtm/tax026.
4
Citation Discovery Tools for Conducting Adaptive Meta-analyses to Update Systematic Reviews.用于进行适应性元分析以更新系统评价的文献引用发现工具。
J Prev Med Public Health. 2016 Mar;49(2):129-33. doi: 10.3961/jpmph.15.074. Epub 2016 Mar 14.
5
A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea.一项口服共生菌(AKSB)预防旅行者腹泻的随机、双盲、安慰剂对照试验。
J Travel Med. 2013 Mar-Apr;20(2):88-94. doi: 10.1111/jtm.12008. Epub 2013 Jan 25.
6
A meta-analysis of probiotic efficacy for gastrointestinal diseases.益生菌治疗胃肠道疾病的疗效的荟萃分析。
PLoS One. 2012;7(4):e34938. doi: 10.1371/journal.pone.0034938. Epub 2012 Apr 18.
7
A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea.一项评估新型半乳糖寡糖混合物减少旅行者腹泻能力的双盲、安慰剂对照、随机人体研究。
Eur J Clin Nutr. 2010 Feb;64(2):146-52. doi: 10.1038/ejcn.2009.120. Epub 2009 Sep 16.
8
Meta-analysis of probiotics for the prevention of traveler's diarrhea.益生菌预防旅行者腹泻的荟萃分析。
Travel Med Infect Dis. 2007 Mar;5(2):97-105. doi: 10.1016/j.tmaid.2005.10.003. Epub 2005 Dec 5.
9
Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study.非活性嗜酸乳杆菌预防旅行者腹泻无效:一项随机、双盲、对照研究。
Clin Infect Dis. 2006 Nov 1;43(9):1170-5. doi: 10.1086/508178. Epub 2006 Sep 27.
10
Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials.益生菌预防急性腹泻的疗效:一项对盲法、随机、安慰剂对照试验的荟萃分析。
Lancet Infect Dis. 2006 Jun;6(6):374-82. doi: 10.1016/S1473-3099(06)70495-9.